<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate degree of sedation and cardiovascular, respiratory, acid-base excess, and electrolyte variables in response to IM administration of <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi> or <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi> with <z:chebi fb="28" ids="16684">atropine</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Randomized crossover study </plain></SENT>
<SENT sid="2" pm="."><plain>Animals-5 healthy 1- to 2-year-old sexually intact male Treeing Walker Coonhounds </plain></SENT>
<SENT sid="3" pm="."><plain>PROCEDURES: Dogs were instrumented with catheters placed in the dorsal pedal artery and lateral saphenous vein </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> dogs received <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi> (10 μg/kg [4.5 μg/lb], IM) or <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi> with <z:chebi fb="28" ids="16684">atropine</z:chebi> (0.02 mg/kg [0.009 mg/lb], IM) </plain></SENT>
<SENT sid="5" pm="."><plain>Variables were measured at baseline (time 0) and 5, 15, 30, and 60 minutes after drug administration </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In <z:hpo ids='HP_0000001'>all</z:hpo> dogs, <z:chebi fb="32" ids="30145">lithium</z:chebi> dilution cardiac output decreased from a mean ± SD baseline value of 5.07 ± 1.0 L/min to 2.1 ± 0.9 L/min </plain></SENT>
<SENT sid="7" pm="."><plain>Cardiac output was not different between <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi> group dogs and <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi>-<z:chebi fb="28" ids="16684">atropine</z:chebi> group dogs </plain></SENT>
<SENT sid="8" pm="."><plain>Mean arterial pressure increased from baseline in both groups but was significantly higher in <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi>-<z:chebi fb="28" ids="16684">atropine</z:chebi> group dogs, compared with <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi> group dogs </plain></SENT>
<SENT sid="9" pm="."><plain>Heart rate in <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi> group dogs decreased from 110 ± 14.2 beats/min to 49.4 ± 10.4 beats/min by 15 minutes </plain></SENT>
<SENT sid="10" pm="."><plain>No differences were seen in blood gas values, electrolyte concentration, or <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> values over time or between groups </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0011675'>Arrhythmias</z:hpo> were detected in <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi>-<z:chebi fb="28" ids="16684">atropine</z:chebi> group dogs and included <z:hpo ids='HP_0001678'>atrioventricular block</z:hpo>, <z:mp ids='MP_0009732'>ventricular premature contractions</z:mp>, and ventricular bigeminy </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS AND CLINICAL RELEVANCE: Administration of <z:chebi fb="28" ids="16684">atropine</z:chebi> at 0.02 mg/kg, IM, with <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi> at 10 μg/kg, IM, resulted in an increase in mean arterial blood pressure and heart rate; deleterious <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> were also observed </plain></SENT>
<SENT sid="13" pm="."><plain>Use of <z:chebi fb="28" ids="16684">atropine</z:chebi> with <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi> is not recommended in dogs </plain></SENT>
</text></document>